Gregory Grunberg

Insider Reports History

Location
Waltham, MA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Gregory Grunberg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Grunberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kala Pharmaceuticals, Inc. Director Common Stock 2,877,006 $19,391,020 $6.74 17 Jun 2021 By Longitude Venture Partners II, L.P.
Kala Pharmaceuticals, Inc. Director Common Stock 2,534,854 $17,084,916 $6.74 17 Jun 2021 By Longitude Venture Partners IV, L.P.
Kala Pharmaceuticals, Inc. Director Common Stock 40,000 $269,600 $6.74 17 Jun 2021 Direct
89bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 27,400 09 Feb 2023 Direct

Insider Reports Filed by Gregory Grunberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ETNB 89bio, Inc. 09 Feb 2023 1 $0 4 Director, 10%+ Owner 13 Feb 2023, 16:34
ETNB 89bio, Inc. 16 May 2022 1 $0 4 Director 18 May 2022, 16:05
KALA Kala Pharmaceuticals, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:30